Table 3. Association Between Subsequent Mortality and Change in Score from Baseline (Randomization) to 48 Weeks, Adjusted for Baseline VACS Index Score.
At Risk | Died | % Died | HR | LCL | UCL | p | ||
Restricted Index Change | ||||||||
Baseline VACS Index (per 5 points) | 1.30 | 1.23 | 1.37 | <.0001 | ||||
Best 25% | <−11 | 73 | 16 | 22% | 0.39 | 0.22 | 0.70 | 0.001 |
Central 50% (Reference) | −11 to 0 | 164 | 49 | 30% | 1.00 | |||
Worst 25% | >0 | 60 | 21 | 35% | 1.51 | 0.90 | 2.53 | 0.12 |
VACS Index Change | ||||||||
Baseline VACS Index (per 5 points) | 1.33 | 1.26 | 1.40 | <0.0001 | ||||
Best 25% | <−11 | 74 | 13 | 18% | 0.26 | 0.14 | 0.40 | <0.0001 |
Central 50% (Reference) | −11 to 9 | 156 | 46 | 29% | 1.00 | |||
Worst 25% | >9 | 67 | 27 | 40% | 2.08 | 1.27 | 3.38 | 0.003 |
Change in index score from baseline was assessed for 297/324324 patients surviving to 48 weeks. Risk of subsequent death was assessed by quartile with the central 50% serving as the reference group.